参考文献/References:
[1] De Vadder F,Kovatcheva-Datchary P,Goncalves D,et al.Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits[J].Cell,2014,156(1-2):84-96.DOI:10.1016/j.cell.2013.12.016.
[2] Zhang J,Chen C,Hua S,et al.An updated meta-analysis of cohort studies:diabetes and risk of Alzheimer's disease[J].Diabetes Res Clin Pract,2017,124:41-47.DOI:10.1016/j.diabres.2016.10.024.
[3] Biessels GJ,Despa F.Cognitive decline and dementia in diabetes mellitus:mechanisms and clinical implications[J].Nat Rev Endocrinol,2018,14(10):591-604.DOI:10.1038/s41574-018-0048-7.
[4] Ma Q,Li Y,Li P,et al.Research progress in the relationship between type 2 diabetes mellitus and intestinal flora[J].Biomed Pharmacother,2019,117:109138.DOI:10.1016/j.biopha.2019.109138.
[5] Qin J,Li Y,Cai Z,et al.A metagenome-wide association study of gut microbiota in type 2 diabetes[J].Nature,2012,490(7418):55-60.DOI:10.1038/nature11450.
[6] Heiss CN,Olofsson LE.Gut Microbiota-Dependent Modulation of Energy Metabolism[J].J Innate Immun,2018,10(3):163-171.DOI:10.1159/000481519.
[7] Matey-Hernandez ML,Williams FMK,Potter T,et al.Genetic and microbiome influence on lipid metabolism and dyslipidemia[J].Physiol Genomics,2018,50(2):117-126.DOI:10.1152/physiolgenomics.00053.2017.
[8] Camargo A,Jimenez-Lucena R,Alcala-Diaz JF,et al.Postprandial endotoxemia may influence the development of type 2 diabetes mellitus:From the CORDIOPREV study[J].Clin Nutr,2019,38(2):529-538.DOI:10.1016/j.clnu.2018.03.016.
[9] Clemmensen C,Müller TD,Woods SC,et al.Gut-Brain Cross-Talk in Metabolic Control[J].Cell,2017,168(5):758-774.DOI:10.1016/j.cell.2017.01.025.
[10] Westfall S,Lomis N,Kahouli I,et al.Microbiome,probiotics and neurodegenerative diseases:deciphering the gut brain axis[J].Cell Mol Life Sci,2017,74(20):3769-3787.DOI:10.1007/s00018-017-2550-9.
[11] Wang X,Wang F,Zhang Y,et al.Diabetic cognitive dysfunction is associated with increased bile acids in liver and activation of bile acid signaling in intestine[J].Toxicol Lett,2018,287:10-22.DOI:10.1016/j.toxlet.2018.01.006.
[12] Zhang J,Zhang Y,Yuan Y,et al.Gut microbiota alteration is associated with cognitive deficits in genetically diabetic(Db/db)mice during aging[J].Front Aging Neurosci,2021,13:815562.DOI:10.3389/fnagi.2021.815562.
[13] Liu P,Wu L,Peng G,et al.Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort[J].Brain Behav Immun,2019,80:633-643.DOI:10.1016/j.bbi.2019.05.008.
[14] Zhang Y,Lu S,Yang Y,et al.The diversity of gut microbiota in type 2 diabetes with or without cognitive impairment[J].Aging Clin Exp Res,2021,33(3):589-601.DOI:10.1007/s40520-020-01553-9.
[15] Dalile B,Van Oudenhove L,Vervliet B,et al.The role of short-chain fatty acids in microbiota-gut-brain communication[J].Nat Rev Gastroenterol Hepatol,2019,16(8):461-478.DOI:10.1038/s41575-019-0157-3.
[16] Zhao L,Zhang F,Ding X,et al.Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes[J].Science,2018,359(6380):1151-1156.DOI:10.1126/science.aao5774.
[17] Verhaar BJH,Hendriksen HMA,de Leeuw FA,et al.Gut Microbiota Composition Is Related to AD Pathology[J].Front Immunol,2022,12:794519.DOI:10.3389/fimmu.2021.794519.
[18] Stilling RM,Van de Wouw M,Clarke G,et al.The neuropharmacology of butyrate:The bread and butter of the microbiota-gut-brain axis?[J].Neurochem Int,2016,99:110-132.DOI:10.1016/j.neuint.2016.06.011.
[19] Xu Y,Zhou H,Zhu Q.The Impact of Microbiota-Gut-Brain Axis on Diabetic Cognition Impairment[J].Front Aging Neurosci,2017,9:106.DOI:10.3389/fnagi.2017.00106.
[20] Elia AE,Lalli S,Monsurrò MR,et al.Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis[J].Eur J Neurol,2016,23(1):45-52.DOI:10.1111/ene.12664.
[21] Wu X,Liu C,Chen L,et al.Protective effects of tauroursodeoxycholic acid on lipopolysaccharide-induced cognitive impairment and neurotoxicity in mice[J].Int Immunopharmacol,2019,72:166-175.DOI:10.1016/j.intimp.2019.03.065.
[22] Hooshmandi E,Ghasemi R,Iloun P,et al.The neuroprotective effect of agmatine against amyloid β-induced apoptosis in primary cultured hippocampal cells involving ERK,Akt/GSK-3β,and TNF-α[J].Mol Biol Rep,2019,46(1):489-496.DOI:10.1007/s11033-018-4501-4.
[23] Kang S,Kim CH,Jung H,et al.Agmatine ameliorates type 2 diabetes induced-Alzheimer's disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling[J].Neuropharmacology,2017,113(Pt A):467-479.DOI:10.1016/j.neuropharm.2016.10.029.
[24] Akasaka N,Fujiwara S.The therapeutic and nutraceutical potential of agmatine,and its enhanced production using Aspergillus oryzae[J].Amino Acids,2020,52(2):181-197.DOI:10.1007/s00726-019-02720-7.
[25] Chakraborty S,Lennon JC,Malkaram SA,et al.Serotonergic system,cognition,and BPSD in Alzheimer's disease[J].Neurosci Lett,2019,704:36-44.DOI:10.1016/j.neulet.2019.03.050.
[26] Jones LA,Sun EW,Martin AM,et al.The ever-changing roles of serotonin[J].Int J Biochem Cell Biol,2020,125:105776.DOI:10.1016/j.biocel.2020.105776.
[27] Ruiz-gonzalez C,Roman P,Rueda-Ruzafa L,et al.Effects of probiotics supplementation on dementia and cognitive impairment:A systematic review and meta-analysis of preclinical and clinical studies[J].Prog Neuropsychopharmacol Biol Psychiatry,2021,108:110189.DOI:10.1016/j.pnpbp.2020.110189.
[28] Liu Z,Dai X,Zhang H,et al.Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairment[J].Nat Commun,2020,11(1):855.DOI:10.1038/s41467-020-14676-4.
相似文献/References:
[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(03):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):31.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.007]
[3]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(03):35.[doi:DOI：10.3760/cma.j.issn.1673-4157.2015.01.008]
[4]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(03):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[5]林天烨,方文军.肠道菌群与代谢性疾病的关系[J].国际内分泌代谢杂志,2014,(04):277.[doi:10.3760/cma.j.issn.1673-4157.2014.04.018]
Lin Tianye*,Fang Wenjun..Relationship between microbiota and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(03):277.[doi:10.3760/cma.j.issn.1673-4157.2014.04.018]
[6]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(03):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
[7]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制
——2014年美国糖尿病协会“杰出科学成就奖”
演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(03):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[8]唐勤,邵莉.蛋白乙酰化与胰岛素分泌[J].国际内分泌代谢杂志,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
Tang Qin,Shao Li..Protein acetylation and insulin secretion[J].International Journal of Endocrinology and Metabolism,2014,(03):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
[9]卢婷婷,任思佳,沈捷.人群迁徙对糖尿病患病率的影响及其相关因素[J].国际内分泌代谢杂志,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
Lu Tingting,Ren Sijia,Shen Jie..Impact of migration on prevalence of diabetes and risk factors[J].International Journal of Endocrinology and Metabolism,2014,(03):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
[10]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(03):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[11]唐榕 木良善.Akkermansia.muciniphila与代谢性疾病[J].国际内分泌代谢杂志,2018,38(01):36.[doi:10.3760/cma.j.issn.1673-4157.2018.01.010]
Tang Rong*,Mu Liangshan.Akkermansia.muciniphila and metabolic diseases[J].International Journal of Endocrinology and Metabolism,2018,38(03):36.[doi:10.3760/cma.j.issn.1673-4157.2018.01.010]